Prostate biopsy status and PSA nadir level as early surrogates for treatment failure: analysis of a prostate cancer randomized radiation dose escalation trial
- 1 November 2002
- journal article
- clinical trial
- Published by Elsevier BV in International Journal of Radiation Oncology*Biology*Physics
- Vol. 54 (3), 677-685
- https://doi.org/10.1016/s0360-3016(02)02977-2
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCERJournal of Urology, 2001
- Postradiotherapy prostate biopsies: what do they really mean? results for 498 patientsInternational Journal of Radiation Oncology*Biology*Physics, 2000
- The correlation of serial prostate specific antigen measurements with clinical outcome after external beam radiation therapy of patients for prostate carcinomaCancer, 2000
- Post-treatment PSA ≤0.2 ng/ml defines disease freedom after radiotherapy for prostate cancer using modern techniquesUrology, 1999
- Cancer Surveillance Series: Interpreting Trends in Prostate Cancer Part I: Evidence of the Effects of Screening in Recent Prostate Cancer Incidence, Mortality, and Survival RatesJNCI Journal of the National Cancer Institute, 1999
- Consensus Statements on Radiation Therapy of Prostate Cancer: Guidelines for Prostate Re-Biopsy After Radiation and for Radiation Therapy With Rising Prostate-Specific Antigen Levels After Radical ProstatectomyJournal of Clinical Oncology, 1999
- Influence of Prostate-Specific Antigen Testing on the Spectrum of Patients With Prostate Cancer Undergoing Radical Prostatectomy at a Large Referral PracticeMayo Clinic Proceedings, 1998
- Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implicationsInternational Journal of Radiation Oncology*Biology*Physics, 1994
- Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Do prostatic biopsies 12 months or more after external irradiation for adenocarcinoma, stage III, predict long-term survival?International Journal of Radiation Oncology*Biology*Physics, 1983